Agora Debate · 2026-04-22
For Raj Anand — FormStack ($18K MRR)
You must raise prices and reposition as a premium product immediately, before the market locks you into a low-price identity you cannot escape.
The race to the bottom is not merely a business risk — it is a structural trap that strips you of the one resource every competent ruler requires: virtù, the capacity to act decisively from a position of strength. When I observed Cesare Borgia operate in the Romagna, I extracted a principle my framework names explicitly as transforming constraints into strategic advantages: your current traction at $18K MRR is not proof that low prices work — it is raw material you can convert into credibility for a premium repositioning. The customers you have acquired cheaply are your laboratory data. More critically, my construct of demonstrating capability to command respect rather than making moral appeals for sympathy maps precisely here: competing on price is the commercial equivalent of petitioning a powerful patron with arguments about fairness. It signals weakness. Premium pricing signals that you possess something worth protecting — and markets, like princes, respect those who act as though they believe in the value of what they hold.
If my logic wins, you raise prices on new customers this quarter, use current customers as case studies demonstrating ROI, and systematically eliminate any messaging that positions you as the "affordable" option.
The question of price strategy is not a marketing decision — it is a measurement problem, and your data is telling you something precise that you are not yet reading correctly.
My framework begins with a perceptual cue I apply before all others: what does the empirical foundation actually show, stripped of what you want it to show? You have $18K MRR and traction, but you have not yet measured what I would consider the critical variable — the radioactivity of your actual customer base. Just as I discovered that pitchblende was more radioactive than pure uranium content predicted, your instinct that something is wrong with low-price competition is an anomalous signal demanding systematic investigation before strategic repositioning. You are noticing that your customers behave in ways that suggest untested pricing tolerance — that is a measurement gap, not a strategic conclusion. My construct of building comprehensive empirical foundations before committing to theoretical frameworks applies here directly: you do not yet know whether you are underpriced because you have not systematically measured willingness-to-pay across customer segments, usage intensity, and retention curves at current pricing.
If my logic wins, you run a rigorous pricing experiment — raise prices on a new customer cohort, measure retention and conversion with precision — and let that data, not competitive anxiety, dictate your repositioning.
The race to the bottom is already lost before you engage in it — your $18K MRR is not proof that low pricing works, it is proof that you have survived long enough to recognize the trap before it closes.
My perceptual lens reads this situation as a configuration problem, not a pricing problem. The master variable here is not what you charge but whose model of your product's reality is controlling the market's perception. Right now, your competitors are writing that story and you are ratifying it by matching their price floor. This is the epistemic contest framing made concrete: you are losing the information war before any customer conversation begins. The reference decision I draw on is my codified doctrine that supreme strategic excellence means avoiding the battle — and price competition is the battle you must refuse entirely. Competing on price means you have already accepted the enemy's terrain, the enemy's rules, and the enemy's timing. The T'ang and Ts'ai precondition applies here structurally: before you raise prices, you must fracture the market's coalition around "form-builder as commodity" by identifying two or three anchor customers whose use cases are indefensible at any other price point and making their outcomes publicly undeniable.
If my logic wins, you reposition through demonstrated customer outcomes before you change a single price tag — making premium pricing the only coherent conclusion the market can reach.
Marie Curie's insistence on running pricing experiments before acting is the counsel of a laboratory scientist mistaking a political crisis for a controlled variable — Sun Tzu is closer to the truth when he identifies the information war, but he errs by sequencing outcomes before price change, which cedes initiative to competitors who will undercut you while you gather case studies.
My framework's construct of choosing decisive engagement over neutral positioning is precisely what both opponents' approaches violate: Curie's experiment keeps you uncommitted, and Sun Tzu's "reposition before repricing" leaves you stranded at $18K MRR while building social proof that your low-price competitors will simply parasitize. The reference decision I draw on is my counsel to Florence — demonstrate strength and independent capability rather than making appeals that signal you are still negotiating your own worth. Your $18K MRR is the Sinigaglia moment: the trap has sprung in your favor, giving you exactly enough credibility to execute a decisive transition. What you must never do is announce the repositioning through messaging before enacting it through price — the prince who publicizes his strategy before implementing it deserves the vulnerability that follows.
If my updated logic wins, you raise prices on all new customers this quarter, let the price itself communicate the repositioning, and convert your three strongest current customers into named case studies simultaneously — making the premium claim fait accompli before any competitor can respond.
Machiavelli's "Sinigaglia moment" metaphor is rhetorically compelling but epistemically empty — he is treating a business decision like a military ambush, substituting narrative drama for measurement precision, and Sun Tzu compounds this error by sequencing customer outcomes before price change as though repositioning were a propaganda campaign rather than an empirical question with a testable answer.
What my prior round surfaced that demands sharper emphasis: I discovered polonium and radium not by announcing their existence and then finding evidence, but by measuring the anomaly in pitchblende until the evidence was indefensible. Your instinct that price competition feels wrong is exactly the anomalous signal I would never abandon — but Machiavelli wants you to act before you have measured the variable that actually matters, which is whether your current customers would have paid more, and by how much. This is my construct of using empirical precision to drive theoretical revision: you are not choosing between "premium" and "budget" as abstract identities, you are measuring whether the radioactivity is in your product or in your price sensitivity. The distinction determines everything. Run the experiment on one new customer cohort at $28K MRR this quarter, measure conversion rate and time-to-close precisely, and let that single clean dataset resolve what neither Machiavelli's prince-craft nor Sun Tzu's information warfare can tell you from first principles.
Curie is measuring the wrong variable — her $28K MRR cohort experiment will tell you conversion rates, but it cannot tell you whether you have already permanently contaminated your market position by fighting on price terrain, which is the upstream configuration failure her laboratory framing is structurally blind to; and Machiavelli's "raise prices simultaneously with case studies" collapses the sequence that makes premium repositioning durable rather than merely announced.
What the prior round surfaced that I must sharpen: the T'ang and Ts'ai precondition is not a sequencing preference, it is a logical necessity — premium pricing without prior outcome architecture is a declaration without an army behind it. My perceptual lens reads your situation as an epistemic contest where your competitors currently control the market's model of what a form-builder is worth, and you cannot win that contest by changing a number on a pricing page while that hostile narrative remains intact. The reference decision I draw on is my doctrine that the coalition must be fractured before contact: two or three anchor customers whose outcomes are publicly undeniable do not merely support premium pricing, they make commodity pricing for your product literally incoherent to any new buyer who encounters them.
If my updated logic wins, you identify your three highest-ROI customers this month, make their outcomes publicly undeniable through documented case studies, and only then raise prices — because by that point, the market has no other rational conclusion to reach.
I concede to Sun Tzu that anchor customer outcomes are not mere decorative evidence — they are load-bearing architecture, and I was too hasty in dismissing the sequencing logic entirely. Yet where I hold firm against both opponents is on the question of initiative: Sun Tzu's framework requires you to complete the case study work before touching the price, which hands weeks or months of runway to competitors who will observe your customer development activities and undercut you preemptively; and Curie's cohort experiment is the most dangerous counsel of all, because it mistakes a political identity question for a laboratory variable — your market position is not radium awaiting discovery, it is a reputation being actively written by competitors every day you remain uncommitted. The prince who waits for perfect measurement before acting has already surrendered the field to those who moved without it. My revised position is this: raise prices on new customers immediately, and run the case study development in parallel, not in sequence — the price change itself signals the repositioning and buys you the psychological authority to make anchor customers take the documentation work seriously.
The single most important thing you must take away: price is not a measurement instrument, it is a declaration of identity — and you must make that declaration before the market makes it for you.
I concede to Machiavelli that parallel execution has force — running case study development simultaneously with price increases rather than sequentially is not reckless, and I was too rigid in treating the experiment as a prerequisite that must complete before any repositioning signal reaches the market.
What I hold firm on is this: Machiavelli's framing that price is "a declaration of identity" rather than a measurement instrument is precisely the kind of theoretical assertion that my framework treats as the beginning of an investigation, not its conclusion. He is telling you what raising prices means before measuring what it does — and that inversion has destroyed more promising scientific programs than any competitor ever has. Sun Tzu correctly identifies that commodity narrative must be fractured, but neither of them can tell you from first principles whether your current customers represent a segment with genuine untested pricing tolerance or a cohort that only exists because of low prices — that distinction is empirically resolvable within one quarter, and resolving it determines whether you are repositioning from strength or performing confidence you have not yet earned.
The single most important thing you must take away: your $18K MRR is an anomalous signal demanding precise measurement before strategic commitment — run one new-customer cohort at a meaningfully higher price point this quarter, measure conversion and retention with rigor, and let that clean dataset, not competitive anxiety or political metaphor, write your next chapter.
I concede to Machiavelli that parallel execution has real force — waiting for case studies to fully publish before touching the price line is slower than necessary, and the price change itself does accelerate the credibility work by signaling that something has shifted.
What I hold firm on against both opponents is the upstream configuration logic they cannot see from their frameworks: Curie's cohort experiment measures conversion rates in a market whose narrative you have not yet disrupted, which means she is measuring the wrong equilibrium — the one where buyers still categorize you as a commodity; and Machiavelli's declaration-first framing treats price as a psychological signal to buyers when the more dangerous audience is your own current customers, who will experience a price increase as betrayal unless anchor outcomes have already rewritten what your product demonstrably is. Premium pricing without documented ROI architecture behind it is not a declaration of identity — it is a claim without an army, which my doctrine categorizes as the fastest route to a credibility collapse that no subsequent experiment can repair.
The single most important thing you must take away: identify your two or three highest-ROI customers this month, make their outcomes publicly undeniable, and raise prices simultaneously — because the case study work is not preparation for the repositioning, it is the repositioning, and the price change is merely its confirmation.
Council Consensus
All three minds agree that your $18K MRR at low prices is a temporary foothold, not a sustainable identity, and that price competition in a commoditized market is a structural trap you must exit. All three also converged by Round 3 on parallel execution — raising prices and building anchor customer case studies simultaneously rather than sequentially. Finally, all agree that your current customers represent the raw material for the repositioning, not obstacles to it.
The core disagreement is about sequencing and evidence: Curie insists you must measure willingness-to-pay with a controlled cohort experiment before committing your identity to premium, while Machiavelli argues price itself is the identity declaration and waiting for data surrenders initiative to competitors. Sun Tzu splits the difference but insists that anchor customer outcomes must be publicly undeniable before the price change lands on existing customers, or you risk a credibility collapse that no experiment can repair. These three positions reflect a genuine tradeoff between measurement rigor, political momentum, and narrative architecture.
This quarter, identify your two or three highest-ROI current customers, begin documenting their outcomes as case studies immediately, and raise prices on all new customers to at least $28K MRR within 30 days — running both tracks in parallel, not in sequence. Do not wait for the case studies to publish before changing the price, but do not raise prices on existing customers until at least one anchor case study is live and undeniable. Let the new price signal the repositioning and the published outcome make it credible.
The most important warning comes from Sun Tzu: raising prices before any documented ROI architecture exists risks a credibility collapse where new buyers see a higher number with no evidence behind it, converting your price signal into a red flag rather than a premium marker. Curie's secondary warning is also real — if your current customer base exists purely because of low prices and has no latent willingness to pay more, you could stall your new-customer pipeline without realizing it until your MRR growth rate collapses. Mitigate both by treating the case study development as genuinely urgent infrastructure, not a marketing afterthought.
This is a sample debate on a hypothetical decision. Bring your own — the council argues differently every time.
Run your own decision →